Anh Tuan Nguyen. "Real-world outcomes of first-line afatinib in advanced non–small cell lung cancer patients with uncommon EGFR mutations at Vietnam National Cancer Hospital.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.19_suppl.277